Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (341-350 of 484) with videos related to

Pageof 49
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2013
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trialMarian L Neuhouser, Elizabeth A Platz, Cathee Till, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|September 3, 2008
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in malesChristina Wang, Eberhard Nieschlag, Ronald S Swerdloff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 30, 2021
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent ProgressionPhillip M Kemp Bohan, Robert C Chick, Anne E O'Shea, et al.
Cancer Research|May 28, 2021
Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate CancerPawel A Osmulski, Alessandra Cunsolo, Meizhen Chen, et al.
Carcinogenesis|April 10, 2013
Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomasTze-Ta Huang, Cara B Gonzales, Fei Gu, et al.
The Journal of Urology|July 24, 2007
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge ConferencePhilip W Kantoff, Tomasz M Beer, Anthony V D'Amico, et al.
European Urology|September 3, 2008
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendationsChristina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al.
Pageof 49

Showing results (341-350 of 484) with videos related to

Sort By:
Pageof 49
Cancer Prevention Research (Philadelphia, Pa.)|January 15, 2013
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trialMarian L Neuhouser, Elizabeth A Platz, Cathee Till, et al.
Urology|February 5, 2008
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancerElisabeth I Heath, Michael W Kattan, Isaac J Powell, et al.
The Journal of Urology|November 5, 2016
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance StudyLiam C Macleod, William J Ellis, Lisa F Newcomb, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|September 3, 2008
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in malesChristina Wang, Eberhard Nieschlag, Ronald S Swerdloff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 30, 2021
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent ProgressionPhillip M Kemp Bohan, Robert C Chick, Anne E O'Shea, et al.
Cancer Research|May 28, 2021
Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate CancerPawel A Osmulski, Alessandra Cunsolo, Meizhen Chen, et al.
Carcinogenesis|April 10, 2013
Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomasTze-Ta Huang, Cara B Gonzales, Fei Gu, et al.
The Journal of Urology|July 24, 2007
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge ConferencePhilip W Kantoff, Tomasz M Beer, Anthony V D'Amico, et al.
European Urology|September 3, 2008
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendationsChristina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al.
Pageof 49